Press release

Mark Foster Appointed to CEO of Trice Medical

Sponsored by Businesswire

announced today the appointment of Mark Foster, President of
Trice Medical, to President and Chief Executive Officer, effective June
30, 2019. Foster joined Trice in 2016, serving as V.P. of Global Sales
and CCO and was promoted
to President in March 2018
. Prior to coming to Trice, Mark served as
V.P. of U.S. Business for Smith and Nephew and in several leadership
roles at Boston Scientific. Current CEO, Jeffrey F. O’Donnell Sr., will
be retiring but will remain active with Trice as a Strategic Advisor.

“I am thrilled to make this announcement,” said O’Donnell, “I am very
proud of the whole team at Trice Medical and what we have achieved in
the past six years. Mark joined Trice with a strong set of ‘big company
skills’ – quickly adding value while also learning how different
‘start-ups’ are. I look forward to assisting him in his transition to
his new role as the CEO of an emerging growth company.”

“I’ve had the opportunity to work closely with both Jeff and Mark for
several years,” added Gary Kurtzman, chairman of the board at Trice.
“Jeff’s passion and drive have gotten us to this point. We will continue
to leverage his skills and expertise as we enter the next stage of
expansion and growth under Mark’s leadership.”

Trice recently announced the launch of the mi-ultra® and the acquisition
of S.E.G-WAY™
Orthopedics (SegWAY). “Our mission is to build a great
company that enhances quality of life,” commented Foster. “An in-office
mi-eye® or mi-ultra® procedure allows the patient and surgeon to get
instant, accurate information and by adding SegWAY, we now have a more
diversified portfolio to treat patients with many different soft-tissue
injuries, including the rapidly growing Endoscopic Carpal Tunnel Market.
I am looking forward to leading our team to bring even more innovative
technology that brings value to patients, physicians and payers,” Foster

About Trice Medical:

Trice Medical was founded to fundamentally improve minimally invasive
orthopedic diagnostics for the patient and physician providing instant
answers. Trice Medical has pioneered fully integrated camera-enabled
technology with the mi-eye 2™ and launched the world’s first Dynamic
Imaging Platform combining a 15 MHz handheld ultrasound transducer with
the mi-eye™ technology on one simple, portable platform. Trice Medical’s
goal is to provide more immediate and definitive patient care,
eliminating the false reads associated with current indirect modalities
and significantly reducing the overall cost to the healthcare system. To
learn more visit